The Journal of Immunology, Vol 151, Issue 10 5545-5553, Copyright © 1993 by American Association of Immunologists

ARTICLES

Characterization of factor H binding to human polymorphonuclear leukocytes

VM Avery and DL Gordon
Department of Microbiology and Infectious Diseases, Flinders Medical Centre, Bedford Park, Australia.

Previous studies indicate that factor H (fH) binds to a number of cell types and may have functions other than C regulation. We have examined for fH binding to PMN using flow cytometry and radiolabeled binding assays. Binding of fH was demonstrated to be specific and saturable with approximately 6 x 10(4) binding sites/polymorphonuclear leukocytes (PMN) and a Ka value of 3.3 x 10(8) L/M. Binding of fH to PMN was ionic strength dependent, required divalent cations, and was enhanced by PMN stimulation with FMLP and calcium ionophore, A23187. The 38-kDa N- terminal tryptic fragment of fH bound to PMN and blocking experiments with mAb suggested a receptor binding site was located within the fifth SCR of fH. fH binding was not due to associations with surface-bound C3 or to CR3. Binding of fH to U937 and Raji cells, but not to T cells was also demonstrated. These studies provide presumptive evidence for a fHR on PMN. Binding of fH by fHR could enhance recognition of opsonized targets, trigger secondary intracellular events or contribute to intrinsic protection of cells against C.

This article has been cited by other articles:

				J. L. McRae, T. G. Duthy, K. M. Griggs, R. J. Ormsby, P. J. Cowan, B. A. Cromer, W. J. McKinstry, M. W. Parker, B. F. Murphy, and D. L. Gordon Human Factor H-Related Protein 5 Has Cofactor Activity, Inhibits C3 Convertase Activity, Binds Heparin and C-Reactive Protein, and Associates with Lipoprotein J. Immunol., May 15, 2005; 174(10): 6250 - 6256. [Abstract] [Full Text] [PDF]

				M. T. Holmberg, A. M. Blom, and S. Meri Regulation of Complement Classical Pathway by Association of C4b-Binding Protein to the Surfaces of SK-OV-3 and Caov-3 Ovarian Adenocarcinoma Cells J. Immunol., July 15, 2001; 167(2): 935 - 939. [Abstract] [Full Text] [PDF]

				S. Junnikkala, T. S. Jokiranta, M. A. Friese, H. Jarva, P. F. Zipfel, and S. Meri Exceptional Resistance of Human H2 Glioblastoma Cells to Complement-Mediated Killing by Expression and Utilization of Factor H and Factor H-Like Protein 1 J. Immunol., June 1, 2000; 164(11): 6075 - 6081. [Abstract] [Full Text] [PDF]

				T. K. Blackmore, V. A. Fischetti, T. A. Sadlon, H. M. Ward, and D. L. Gordon M Protein of the Group A Streptococcus Binds to the Seventh Short Consensus Repeat of Human Complement Factor H Infect. Immun., April 1, 1998; 66(4): 1427 - 1431. [Abstract] [Full Text] [PDF]

				W.-X. Shi, R. Chammas, N. M. Varki, L. Powell, and A. Varki Sialic Acid 9-O-Acetylation on Murine Erythroleukemia Cells Affects Complement Activation, Binding to I-type Lectins, and Tissue Homing J. Biol. Chem., December 6, 1996; 271(49): 31526 - 31532. [Abstract] [Full Text] [PDF]

				J. J. Alexander, B. K. Hack, P. N. Cunningham, and R. J. Quigg A Protein with Characteristics of Factor H Is Present on Rodent Platelets and Functions as the Immune Adherence Receptor J. Biol. Chem., August 17, 2001; 276(34): 32129 - 32135. [Abstract] [Full Text] [PDF]